Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/union-therapeutics-to-present-at-7th-annual-dermatology-drug-development-summit-in-boston-301966928.html
https://www.prnewswire.com/news-releases/union-therapeutics-announces-presentation-of-new-data-on-orismilast-at-the-eadv-congress-2023-301949287.html
https://www.fiercebiotech.com/cro/altis-labs-reels-6m-seed-funding-ai-imaging-used-clinical-trials
https://www.prnewswire.com/news-releases/union-therapeutics-to-participate-at-kempen-life-science-conference-301804056.html
https://www.pharmaceutical-technology.com/news/fda-union-oral-orismilast-hs/
https://www.prnewswire.com/news-releases/union-therapeutics-announces-positive-topline-results-from-the-iasos-phase-2b-study-of-oral-orismilast-in-patients-with-moderate-to-severe-psoriasis-301716687.html
https://news.cision.com/union-therapeutics/r/first-large-scale-analysis-confirms-that-vulnerable-patients-remain-at-increased-fatality-to-covid-1,c3691756
https://www.prnewswire.com/news-releases/innovent-and-union-therapeutics-announce-first-subject-dosed-in-a-chinese-clinical-phase-i-study-of-the-novel-pde4-inhibitor-orismilast-ibi353-301692408.html
https://uniontherapeutics.com/union-therapeutics-presents-new-data-on-orismilast-at-the-31st-eadv-congress-supporting-orismilasts-potential-as-a-first-in-class-or-best-in-class-treatment-for-certain-immunological-diseases/
https://news.cision.com/union-therapeutics/r/union-therapeutics-announces-regulatory-approval-of-treatment-extension-for-the-ongoing-osiris-phase,c3624685